Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1012 of 1,261
  1. US 7658364

    Ocular therapeutic agent delivery devices and methods for making and using such devices

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted
  2. US 7659082

    Methods for identifying analgesic agents

    Xenon Pharmaceuticals Inc. · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted
  3. US 7659118

    Multipotent adult stem cells

    Regents of the University of Minnesota · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted
  4. US 7658923

    Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26

    The Board of Regents of the University of Texas System · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted
  5. US 7659283

    Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted
  6. US 7659267

    1,3-Benzothiazinone derivatives, process for producing the same use thereof

    Takeda Pharmaceutical Company Limited · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted
  7. US 7655797

    Intermediates for making 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  8. US 7655685

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Jenrin Discovery, LLC · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  9. US 7655621

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  10. US 7655747

    Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution

    Nektar Therapeutics · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  11. US 7655695

    Illudin analogs useful as anticancer agents

    The Regents of the University of California · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  12. US 7655722

    Adhesive composition

    Kuraray Medical Inc. · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  13. US 7655241

    Methods and compositions for vaccination against or involving enterobacteriaceae bacteria

    The Board of Regents of the University of Texas System · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  14. US 7655247

    Malaria vaccines

    The Government of the United States, as Respresented by the Secretary of the Army · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  15. US 7655252

    Antimicrobial nanoemulsion compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  16. US 7655397

    Selections of genes and methods of using the same for diagnosis and for targeting the therapy of select cancers

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  17. US 7655665

    Nitromethylene derivatives and their use

    East China University of Science and Technology · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  18. US 7655474

    Trioxyethylene gold nanoclusters functionalized with a single DNA

    United States of America as represented by the Secretary of the Air Force · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  19. US 7655472

    Treatment of disease by inducing cell apoptosis

    The Regents of the University of California · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  20. US 7655694

    Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  21. US 7655762

    Monoclonal antibodies against ANGPTL4

    LEXICON PHARMACEUTICALS, INC. · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  22. US 7655758

    Stable liquid IL-1 antagonist formulations

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  23. US 7655752

    TNF-α converting enzyme inhibitory agents and method of using same

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  24. US 7655781

    Variants of human glycoprotein hormone alpha chain: compositions and uses thereof

    Protalix Ltd. · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.